118 related articles for article (PubMed ID: 10930999)
1. T-cell expansions in patients with multiple myeloma have a phenotype of cytotoxic T cells.
Raitakari M; Brown RD; Sze D; Yuen E; Barrow L; Nelson M; Pope B; Esdale W; Gibson J; Joshua DE
Br J Haematol; 2000 Jul; 110(1):203-9. PubMed ID: 10930999
[TBL] [Abstract][Full Text] [Related]
2. Clonal cytotoxic T cells are expanded in myeloma and reside in the CD8(+)CD57(+)CD28(-) compartment.
Sze DM; Giesajtis G; Brown RD; Raitakari M; Gibson J; Ho J; Baxter AG; Fazekas de St Groth B; Basten A; Joshua DE
Blood; 2001 Nov; 98(9):2817-27. PubMed ID: 11675356
[TBL] [Abstract][Full Text] [Related]
3. Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire.
Pérez-Andres M; Almeida J; Martin-Ayuso M; Moro MJ; Martin-Nuñez G; Galende J; Hernandez J; Mateo G; San Miguel JF; Orfao A; ;
Cancer; 2006 Mar; 106(6):1296-305. PubMed ID: 16475149
[TBL] [Abstract][Full Text] [Related]
4. Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia.
Kook H; Zeng W; Guibin C; Kirby M; Young NS; Maciejewski JP
Exp Hematol; 2001 Nov; 29(11):1270-7. PubMed ID: 11698122
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of human CD8 T cells: implications for in vivo persistence of CD8+ CD28- cytotoxic effector clones.
Posnett DN; Edinger JW; Manavalan JS; Irwin C; Marodon G
Int Immunol; 1999 Feb; 11(2):229-41. PubMed ID: 10069421
[TBL] [Abstract][Full Text] [Related]
6. T cell repertoire in patients with multiple myeloma and monoclonal gammopathy of undetermined significance: clonal CD8+ T cell expansions are found preferentially in patients with a low tumor burden.
Halapi E; Werner A; Wahlström J; Osterborg A; Jeddi-Tehrani M; Yi Q; Janson CH; Wigzell H; Grunewald J; Mellstedt H
Eur J Immunol; 1997 Sep; 27(9):2245-52. PubMed ID: 9341766
[TBL] [Abstract][Full Text] [Related]
7. Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a Study of the Eastern Cooperative Oncology Group (E9487).
Kay N; Leong T; Kyle RA; Greipp P; Van Ness B; Bone N; Oken MM
Leuk Lymphoma; 1999 Mar; 33(1-2):127-33. PubMed ID: 10194129
[TBL] [Abstract][Full Text] [Related]
8. Activated alpha beta-CD8+, but not alpha alpha-CD8+, TCR-alpha beta+ murine intestinal intraepithelial lymphocytes can mediate perforin-based cytotoxicity, whereas both subsets are active in Fas-based cytotoxicity.
Gelfanov V; Gelfanova V; Lai YG; Liao NS
J Immunol; 1996 Jan; 156(1):35-41. PubMed ID: 8598484
[TBL] [Abstract][Full Text] [Related]
9. Clonal CD8+ TCR-Vbeta expanded populations with effector memory phenotype in Churg Strauss syndrome.
Guida G; Vallario A; Stella S; Boita M; Circosta P; Mariani S; Prato G; Heffler E; Bergia R; Sottile A; Rolla G; Cignetti A
Clin Immunol; 2008 Jul; 128(1):94-102. PubMed ID: 18502180
[TBL] [Abstract][Full Text] [Related]
10. Large clonal expansions of human virus-specific memory cytotoxic T lymphocytes within the CD57+ CD28- CD8+ T-cell population.
Weekes MP; Wills MR; Mynard K; Hicks R; Sissons JG; Carmichael AJ
Immunology; 1999 Nov; 98(3):443-9. PubMed ID: 10583606
[TBL] [Abstract][Full Text] [Related]
11. CD8alpha alpha memory effector T cells descend directly from clonally expanded CD8alpha +beta high TCRalpha beta T cells in vivo.
Konno A; Okada K; Mizuno K; Nishida M; Nagaoki S; Toma T; Uehara T; Ohta K; Kasahara Y; Seki H; Yachie A; Koizumi S
Blood; 2002 Dec; 100(12):4090-7. PubMed ID: 12393564
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotypic analysis of the TCR-Vbeta repertoire in 98 persistent expansions of CD3(+)/TCR-alphabeta(+) large granular lymphocytes: utility in assessing clonality and insights into the pathogenesis of the disease.
Lima M; Almeida J; Santos AH; dos Anjos Teixeira M; Alguero MC; Queirós ML; Balanzategui A; Justiça B; Gonzalez M; San Miguel JF; Orfão A
Am J Pathol; 2001 Nov; 159(5):1861-8. PubMed ID: 11696446
[TBL] [Abstract][Full Text] [Related]
13. Clonality detection of expanded T-cell populations in patients with multiple myeloma.
Sze DM
Methods Mol Med; 2005; 113():257-67. PubMed ID: 15968109
[TBL] [Abstract][Full Text] [Related]
14. Prognostically significant cytotoxic T cell clones are stimulated after thalidomide therapy in patients with multiple myeloma.
Brown RD; Spencer A; Ho PJ; Kennedy N; Kabani K; Yang S; Sze DM; Aklilu E; Gibson J; Joshua DE
Leuk Lymphoma; 2009 Nov; 50(11):1860-4. PubMed ID: 19883313
[TBL] [Abstract][Full Text] [Related]
15. Functional and Vbeta repertoire characterization of human CD8+ T-cell subsets with natural killer cell markers, CD56+ CD57- T cells, CD56+ CD57+ T cells and CD56- CD57+ T cells.
Takayama E; Koike Y; Ohkawa T; Majima T; Fukasawa M; Shinomiya N; Yamaguchi T; Konishi M; Hiraide H; Tadakuma T; Seki S
Immunology; 2003 Feb; 108(2):211-9. PubMed ID: 12562330
[TBL] [Abstract][Full Text] [Related]
16. CD8high+ (CD57+) T cells in patients with rheumatoid arthritis.
Wang EC; Lawson TM; Vedhara K; Moss PA; Lehner PJ; Borysiewicz LK
Arthritis Rheum; 1997 Feb; 40(2):237-48. PubMed ID: 9041935
[TBL] [Abstract][Full Text] [Related]
17. Alterations in the T-cell receptor variable beta gene-restricted profile of CD8+ T lymphocytes in the peripheral circulation of patients with squamous cell carcinoma of the head and neck.
Albers AE; Visus C; Tsukishiro T; Ferris RL; Gooding W; Whiteside TL; De Leo AB
Clin Cancer Res; 2006 Apr; 12(8):2394-403. PubMed ID: 16638844
[TBL] [Abstract][Full Text] [Related]
18. Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL).
Porakishvili N; Roschupkina T; Kalber T; Jewell AP; Patterson K; Yong K; Lydyard PM
Clin Exp Immunol; 2001 Oct; 126(1):29-36. PubMed ID: 11678896
[TBL] [Abstract][Full Text] [Related]
19. T cell- and perforin-dependent depletion of B cells in vivo by staphylococcal enterotoxin A.
Sundstedt A; Grundström S; Dohlsten M
Immunology; 1998 Sep; 95(1):76-82. PubMed ID: 9767460
[TBL] [Abstract][Full Text] [Related]
20. Generation of potent antitumor CTL from patients with multiple myeloma directed against HM1.24.
Rew SB; Peggs K; Sanjuan I; Pizzey AR; Koishihara Y; Kawai S; Kosaka M; Ozaki S; Chain B; Yong KL
Clin Cancer Res; 2005 May; 11(9):3377-84. PubMed ID: 15867238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
